Fluorescent and electrochemical detection of nuclease activity associated with Streptococcus pneumoniae using

Garazi Goikoetxea1,2,3, Khadija-Tul Kubra Akhtar1,4,5, Alona Prysiazhniuk1,4,5,6

  • 1Nucleic Acids Technologies Laboratory (NAT-Lab), Linköping University, 58185, Sweden. frank.hernandez@liu.se.

The Analyst
|January 19, 2024
PubMed

Insights

This study identifies a novel biomarker for detecting Streptococcus pneumoniae (S. pneumoniae) using bacterial nucleases. Developed biosensors offer rapid, specific detection of S. pneumoniae in clinical samples.

Area of Science:

  • Biomarker Discovery
  • Biosensor Technology
  • Microbial Pathogenesis

Background:

  • Streptococcus pneumoniae (S. pneumoniae) is a major cause of community-acquired pneumonia.
  • Rapid and accurate detection of S. pneumoniae is crucial for timely treatment and improved patient outcomes.
  • Existing diagnostic methods may lack the speed or sensitivity required for effective clinical management.

Purpose of the Study:

  • To screen and discover a novel biomarker for S. pneumoniae detection.
  • To develop and evaluate fluorescence and electrochemical biosensors utilizing this biomarker.
  • To assess the sensitivity, specificity, and clinical applicability of the developed biosensors.

Main Methods:

  • Utilized S. pneumoniae nucleases as the target biomarker.
  • Identified a specific oligonucleotide substrate for the nuclease activity.
  • Developed fluorescence and electrochemical biosensor platforms based on the nuclease-substrate interaction.
  • Evaluated biosensor performance using bacterial cultures and clinical samples.

Main Results:

  • An electrochemical biosensor achieved a high sensitivity of 10^2 CFU mL-1.
  • A fluorescence biosensor demonstrated a detection limit of 10^6 CFU mL-1.
  • Both biosensors exhibited high specificity, distinguishing S. pneumoniae from other pathogens.
  • Successful detection of S. pneumoniae in clinical samples was achieved.

Conclusions:

  • Novel S. pneumoniae nuclease-based biomarker identified.
  • Electrochemical biosensor shows high sensitivity and potential for rapid diagnostics.
  • Developed biosensors demonstrate clinical utility for S. pneumoniae detection.